Insulin binding and response in erythroblastic leukemic cells.

Area of Science:

• Biochemistry
• Cell Biology
• Endocrinology

Background:

• Mammalian erythrocytes bind but do not respond to insulin at physiologic doses.
• Insulin's role in erythroblast maturation is not fully understood.

Purpose of the Study:

• To investigate insulin binding and response in normal rat erythrocytes and erythroblastic leukemic (EBL) cells.
• To characterize insulin degradation in EBL cells and its impact on binding assays.
• To explore EBL cells as a model for studying insulin's effects on erythroblasts.

Main Methods:

• Standard 125I-insulin competitive binding assays were employed.
• Insulin degradation was assessed and inhibited using bacitracin or bovine serum albumin.
• Scatchard analysis was used to determine receptor numbers.
• Cellular responses, including amino acid transport and RNA synthesis, were measured.

Main Results:

• Erythroblastic leukemic (EBL) cells exhibited significant insulin degradation.
• Insulin binding was over 10-fold greater in EBL cells compared to normal erythrocytes.
• Scatchard analysis indicated an increase in insulin receptors on EBL cells.
• EBL cells showed enhanced alpha-aminoisobutyric acid transport and uridine incorporation in response to insulin.

Conclusions:

• Erythroblastic leukemic (EBL) cells demonstrate increased insulin binding and responsiveness.
• EBL cells possess a higher number of insulin receptors.
• EBL cells serve as a valuable model for investigating insulin binding, response, and cell maturation in erythroblasts.